Raman spectral analysis of pathogens

• US 7,428,045 B2
• Filed: 08/17/2005
• Issued: 09/23/2008
• Est. Priority Date: 01/10/2002
• Status: Expired due to Term

• Current Assignee: Chemimage Corporation
• Original Assignee: Chemimage Corporation
• Inventors: Stewart, Shona, Treado, Patrick J., Maier, John S.
• Primary Examiner(s): EVANS, FANNIE L
• Application Number:
  US11/206,007
• Publication Number:
  US 20060055923A1
• Time in Patent Office: 1,133 Days
• Field of Search: 356/301
• US Class Current: 356/301
• CPC Class Codes: A61B 18/20 using laser
• CPC Class Codes: G01J 3/10 Arrangements of light sources specially adapted for spectrometry or colorimetry
• CPC Class Codes: G01J 3/44 Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
• CPC Class Codes: G01N 2021/6423 Spectral mapping, video display
• CPC Class Codes: G01N 2021/656 Raman microprobe
• CPC Class Codes: G01N 21/31 Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry G01N21/72 takes precedence
• CPC Class Codes: G01N 21/645 Specially adapted constructive features of fluorimeters
• CPC Class Codes: G01N 21/6458 Fluorescence microscopy fluorescence microscopes per se G02B21/0076 and G02B21/16
• CPC Class Codes: G01N 21/6486 Measuring fluorescence of biological material, e.g. DNA, RNA, cells G01N21/6428 takes precedence
• CPC Class Codes: G01N 21/65 Raman scattering
• CPC Class Codes: G01N 21/658 enhancement Raman, e.g. surface plasmons

Abstract

Raman scattering of radiation applied to a water sample is used to assess occurrence of a pathogen in the sample. The method is useful for detecting pathogens that are difficult to detect using other methods, such as protozoa. Examples of organisms that can be detected in water samples using these methods include protozoa of the genus Cryptosporidium and the genus Giardia. The methods described herein have important applications, such as for detection of Cryptosporidium organisms in municipal water systems.

Claims

1. A method of assessing occurrence of a pathogen in a sample, the method comprising:

obtaining a visual microscopic image of the sample, wherein the visual microscopic image includes morphological and structural information representative of the sample;

irradiating the sample to thereby generate Raman scattered radiation; and

identifying the occurrence of the pathogen in the sample by assessing the morphological and structural information for characteristics of the pathogen and the Raman scattered radiation from the sample for radiation that exhibits a Raman shift characteristic of the pathogen.

2. The method of claim 1, wherein the sample is a fluid sample.

3. The method of claim 2, wherein the sample is an aqueous sample.

4. The method of claim 1, wherein the pathogen is a human pathogen.

5. The method of claim 4, wherein the pathogen is a protozoan.

6. The method of claim 5, wherein the pathogen is selected from the group consisting of a protozoan of the genus Cryptosporidium and a protozoan of the genus Giardia.

7. The method of claim 4, wherein the pathogen is a bacterium.

8. The method of claim 7, wherein the bacterium is a bacterium of a genus selected from the group consisting of Escherichia, Yersinia, Francisella, Brucella, Clostridium, Burkholderia, Chlamydia, Coxiella, Rickettsia, Vibrio, Enterococcus, Staphylococcus, Staphylococcus, Enterobacter, Corynebacterium, Pseudomonas, Acinetobacter, Klebsiella, and Serratia.

9. The method of claim 7, wherein the bacterium is selected from the group consisting of Escherichia coli, Yersinia pestis, Francisella tularensis, Clostridium perfringens, Burkholderia mallei, Burkholderia pseudomallei, Chlamydia psittaci, Coxiella burnetii, Rickettsia prowazekii, Vibrio vulnificus, Vibrio enterolyticus, Vibrio fischuii, Vibrio cholera, Enterococcus faecalis, Staphylococcus epidermidis, Staphylococcus aureus, Enterobacter aerogenes, Corynebacterium diphtheriae, Pseudomonas aeruginosa, Acinetobacter calcoaceticus, Klebsiella pneumoniae, and Serratia marcescens.

10. The method of claim 4, wherein the pathogen is a yeast.

11. The method of claim 10, wherein the pathogen is Candida albicans.

12. The method of claim 4, wherein the pathogen is a virus.

13. The method of claim 12, wherein the virus is selected from the group consisting of filoviruses, naviruses, alphaviruses, rotoviruses, calciviruses, and hepatitis viruses.

14. The method of claim 12, wherein the virus is selected from the group of filoviruses consisting of Ebola and Marburg viruses, naviruses, Lassa fever, Machupo viruses, alphaviruses, Venezuelan equine encephalitis, eastern equine encephalitis, western equine encephalitis, rotoviruses, calciviruses, Norwalk virus, hepatitis A virus, hepatitis B virus, hepatitis C virus, biological warfare agents, and smallpox.

15. The method of claim 4, wherein the pathogen is a biological warfare agent.

16. The method of claim 15, wherein the pathogen is selected from the group consisting of bacteria, fungi, bacterial toxins, and viruses.

17. The method of claim 15, wherein the pathogen is selected from the group consisting of Bacillus anthracis, Bartonella quintana, Brucella melitensis, Burkholderia mallei, Burkholderia pseudomallei, Chlamydia psittaci, Clostridium botulinum, Clostridium perfringens, Coxiella burnetti, enterohaemorrhagic Escherichia coli, Francisella tularensis, Rickettsia mooseri, Rickettsia prowasecki, Rickettsia rickettsii, Rickettsia tsutsugamushii, Salmonella typhi, Shigella dysenteriae, Vibrio cholerae, Yersinia pestis, Coccidioides immitis, Histoplasma capsulatum, chikungunya virus, Congo-Crimean haemorrhagic fever virus, dengue fever virus, Eastern equine encephalitis virus, ebola virus, equine morbillivirus, hantaan virus, Japanese encephalitis virus, junin virus, lassa fever virus, lymphocytic choriomeningitis virus, machupo virus, marburg virus, monkey pox virus, Murray valley encephalitis virus, nipah virus, Omsk hemorrhagic fever virus, oropouche virus, Rift valley fever virus, Russian Spring-Summer encephalitis virus, smallpox virus, South American hemorrhagic fever viruses, St. Louis encephalitis virus, tick-borne encephalitis virus, Variola virus, Venezuelan equine encephalitis virus, Western equine encephalitis virus, white pox virus, yellow fever virus, botulinum toxins, Clostridium perfringens toxins, microcystins (Cyanginosins), Shiga toxin, verotoxin, Staphylococcal enterotoxin B, anatoxin A, conotoxins, palytoxin, saxitoxin, tetrodotoxin, stachybotrys toxins, aflatoxins, trichothecenes, satratoxin H, T-2 toxin, and ricin.

18. The method of claim 1, wherein the pathogen is selected from the group consisting of Abrus precatorius lectin, African swine fever virus, avian influenza virus, banana bunchy top virus, bluetongue virus, camelpox virus, cholera toxin, Clostridium perfringens, Clostridium tetani, Cryptosporidium parvum, Deuterophoma tracheiphila, Entamoeba histolytica, ergot alkaloids, Escherichia coli O157, foot and mouth disease virus, Giardia lamblia, goat pox virus, hendra virus, hepatitis A virus, hog cholera virus, human immunodeficiency virus, infectious conjunctivitis virus, influenza virus, Kyasanur Forest virus, Legionella pneumophila, louping ill virus, lyssaviruses, Adenia digitata lectin (modeccin), Monilia rorei, Naegleria fowleri, nipah virus, Murray Valley encephalitis virus, Mycoplasma mycoides, newcastle disease virus, oropouche virus, peste des petits ruminants virus, porcine enterovirus 9, powassan virus, pseudorabies virus, rinderpest virus, rocio virus, group B rotaviruses, Salmonella paratyphi, sheeppox virus, St. Louis encephalitis virus, substance P. Serratia marcescens, Teschen-Talfan virus, tetanus toxin, vesicular stomatitis virus, Viscum album lectin I (Viscumin), Adena volkensii lectin (volkensin), West Nile virus, Xanthomonas campestris oryzae, Xylella fastidiosa, and Yersinia pseudotuberculosis.

19. A method of assessing occurrence of a viable biological pathogen in a sample, the method comprising:

obtaining a visual microscopic image of the sample, wherein the visual microscopic image includes morphological and structural information representative of the sample;

irradiating the sample to thereby generate Raman scattered radiation; and

identifying the occurrence of the viable biological pathogen in the sample by assessing the morphological and structural information for characteristics of the viable biological pathogen and the Raman scattered radiation from the sample for radiation that exhibits a Raman shift characteristic of the viable biological pathogen.